MedTrace Logo

Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis

NCT07523477 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-04-13

No results posted yet for this study

Summary

The aim of this study is to evaluate the outcome of botulinum toxin A (BTX-A) injection for management of children with :

A-Dysfunctional voiding who are not responding to traditional treatment. B-Refractory nocturnal enuresis.

Conditions

  • Local Injection
  • Botulinium Toxin-A
  • Children
  • Dysfunctional Voiding
  • Refractory Nocturnal Eneuresis

Interventions

DRUG

Botulinium Toxin-A

Patients will be injected with botulinium toxin-A

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2026-12-01
Completion
2026-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07523477 on ClinicalTrials.gov